![]() |
市場調查報告書
商品編碼
1954614
培養皿市場規模、佔有率、成長及全球產業分析:依類型、應用和地區劃分的洞察與預測(2026-2034 年)Petri Dishes Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
2025 年全球培養皿市場規模為 4.295 億美元,預計將從 2026 年的 4.468 億美元增長至 2034 年的 6.461 億美元,預測期內(2026-2034 年)複合年增長率 (CAGR) 為 4.70%。 2025 年,北美以 40.20% 的市佔率領先。這得益於醫藥產業強大的研發投入和不斷擴大的醫療基礎設施。
培養皿是淺的、有蓋的玻璃或塑膠培養皿,廣泛用於微生物培養、抗生素療效測試和微生物學研究。慢性病和傳染病的日益普及推動了對藥品、疫苗和治療方法的需求,進而促進了研究活動,並增加了對培養皿等實驗室設備的需求。
新冠疫情的影響
新冠疫情對全球市場產生了正面影響。與疫苗研發、治療方法發現和慢性病研究相關的研究活動增加,促使實驗室設備需求激增。
根據美國科學技術統計中心 (NCSE) 的數據,美國研發投資從 2019 年的 6,661.5 億美元成長到 2020 年的 7,169.5 億美元,增幅達 16.2%。賽默飛世爾科技 (Thermo Fisher Scientific) 2020 年生命科學解決方案部門的表現成長了 77.5%,反映了市場對實驗室設備的強勁需求。疫情後的成長由於實驗室用品的提前採購而趨於正常,但研究的擴展仍在繼續支撐著市場的穩定發展。
市場趨勢
對可生物分解實驗室設備的興趣日益濃厚
人們對一次性塑膠實驗室設備的環境問題日益關注,推動了對可生物降解和可重複使用培養皿的需求。實驗室和永續發展倡議正在推廣環保的實驗室實踐。
例如,2022年11月,奧地利綠色實驗室、默克集團和維也納大學共同舉辦了一場關於永續實驗室解決方案的研討會。這些努力有望促進環保產品創新,並塑造未來的市場趨勢。
市場驅動因素
醫療領域研發活動增加
隨著全球傳染病和慢性病病例的增加,製藥業的研發投資正在擴大。這直接推動了對細胞培養皿及相關耗材的需求。
製藥公司、合約研究組織 (CRO) 和合約生產商 (CMO) 之間日益密切的合作,進一步加速了研發活動和產品上市。
市場限制因子
替代品的日益普及
多孔板和 PCR 板的廣泛應用對傳統培養皿的普及構成了挑戰。多孔板因其高通量和便利性,在高級研究應用中極具吸引力。
例如,賽默飛世爾科技 (Thermo Fisher) 的 96 孔微孔板售價約為 9-10 美元,而默克 (Merck) 的同類產品則以 4-5 美元的價格提供了更具成本效益的選擇。此外,為減少塑膠垃圾,可重複使用的實驗室設備的日益普及也可能限制需求成長。
依產品類型
市場區隔將培養皿分為塑膠培養皿和玻璃培養皿。
依最終使用者劃分
市場細分包括醫院和臨床實驗室、診斷中心、製藥和生物技術公司、學術和研究機構以及其他機構。
北美
預計到2025年,北美將以1.726億美元的市場估值引領市場。研發設施的擴張和製藥投資正在推動成長。例如,賽默飛世爾科技於2023年3月在加州開設了一家細胞治療中心,加速治療藥物的研發。
亞太地區
由於生物製藥生產和分銷中心的擴張,預計亞太地區將以可觀的複合年增長率增長。 2023年7月,Avantar擴大了在新加坡的基地,以加強創新和其生物製藥體系。
歐洲
歐洲佔了較大的市場佔有率,這得益於其在個人化醫療和永續實驗室運作方面的努力。 2022年,SARSTEDT AG等公司推出了創新細胞培養板,旨在提高研究效率。
拉丁美洲、中東和非洲
由於製藥業的合作以及醫療基礎設施建設的進步,例如默克公司在尼日利亞的疫苗設施支持計劃,預計這些地區將穩步增長。
The global petri dishes market was valued at USD 429.5 million in 2025 and is projected to grow from USD 446.8 million in 2026 to USD 646.1 million by 2034, exhibiting a CAGR of 4.70% during the forecast period (2026-2034). In 2025, North America dominated the market with a 40.20% share, supported by strong pharmaceutical R&D investments and expanding healthcare infrastructure.
Petri dishes are shallow, lidded plates made of glass or plastic, widely used for culturing microorganisms, testing antibiotic efficacy, and conducting microbiological research. Growing prevalence of chronic and infectious diseases is increasing the demand for drugs, vaccines, and therapies, thereby fueling research activities and boosting demand for labware products such as petri dishes.
COVID-19 Impact
The COVID-19 pandemic had a positive impact on the global market. Increased research activities related to vaccine development, treatment discovery, and chronic disease studies led to a surge in labware demand.
According to the National Center for Science and Engineering Statistics, U.S. R&D investment increased by 16.2% to USD 716.95 billion in 2020, compared to USD 666.15 billion in 2019. Thermo Fisher Scientific reported a 77.5% growth in its life sciences solutions segment in 2020, reflecting strong labware demand. Although growth normalized post-pandemic due to prior procurement of lab supplies, research expansion continues to support steady market progress.
Market Trends
Growing Focus on Biodegradable Labware
Environmental concerns surrounding single-use plastic labware are driving demand for biodegradable and reusable petri dishes. Research institutes and sustainability initiatives are encouraging green laboratory practices.
For example, in November 2022, Green Labs Austria, Merck KGaA, and the University of Vienna organized a workshop on sustainable lab solutions. Such initiatives are expected to promote eco-friendly product innovations and shape future market trends.
Market Drivers
Increasing R&D Activities in Healthcare
Rising global cases of infectious and chronic diseases are increasing pharmaceutical R&D investments. This directly drives demand for cell culture dishes and related consumables.
Growing collaborations between pharmaceutical companies, CROs, and CMOs are further accelerating research activities and product adoption.
Market Restraints
Rising Adoption of Alternatives
The increasing use of multiwell plates and PCR plates poses a challenge to traditional petri dish adoption. Multiwell plates offer high-throughput capabilities and convenience, making them attractive for advanced research applications.
For example, Thermo Fisher's 96-well microplates are priced around USD 9-10, while Merck's equivalent products cost USD 4-5, offering cost-efficient alternatives. Additionally, growing adoption of reusable labware to reduce plastic waste may limit demand growth.
By Product Type
The market is segmented into plastic and glass petri dishes.
By End-User
The market is segmented into hospital & clinical laboratories, diagnostic centers, pharmaceutical & biotechnology companies, academic & research institutes, and others.
North America
North America led the market with a valuation of USD 172.6 million in 2025. Growth is supported by expanding R&D facilities and pharmaceutical investments. For instance, in March 2023, Thermo Fisher opened a cell therapy facility in California to accelerate therapy development.
Asia Pacific
Asia Pacific is expected to grow at a considerable CAGR due to expanding biopharma manufacturing and distribution centers. In July 2023, Avantor expanded its Singapore hub to strengthen innovation and biopharma systems.
Europe
Europe holds a significant share, supported by personalized therapy initiatives and sustainable lab practices. Companies like SARSTEDT AG launched innovative cell culture plates in 2022 to enhance research efficiency.
Latin America & Middle East & Africa
These regions are expected to grow steadily due to increasing pharmaceutical collaborations and healthcare infrastructure development, such as Merck's vaccine facility support initiative in Nigeria.
Competitive Landscape
The market is fragmented, with leading players focusing on innovation, facility expansion, and partnerships. Key companies include:
Recent collaborations, product launches, and sustainability initiatives are strengthening competitive positioning.
Conclusion
The global petri dishes market is poised for steady growth, rising from USD 429.5 million in 2025 to USD 646.1 million by 2034, at a CAGR of 4.70%. Growth is primarily driven by expanding pharmaceutical R&D activities, increasing chronic disease prevalence, and advancements in cell culture research. While alternative labware products and sustainability concerns pose challenges, continuous innovation and rising global research investments will sustain market expansion through 2034.
Segmentation By Product Type
By End-user
By Region